Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can change how food tastes and smells for some people. Semaglutide affects appetite-signalling pathways in the brain, and a meaningful number of patients report that previously appealing foods (especially fatty or highly processed ones) lose their pull, or take on a different quality entirely. This isn't a side effect listed in the same breath as nausea, but it's real, and understanding what's behind it helps you work with it rather than against it. As a prescription-only medicine, Wegovy is assessed and dispensed through clinical review; a prescriber will discuss how it's likely to affect you personally before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy (semaglutide) works primarily as a GLP-1 receptor agonist. GLP-1 is a gut hormone that signals fullness to the brain, slows gastric emptying, and quiets the appetite-driving circuits in the hypothalamus. What's less widely discussed is that GLP-1 receptors are also present in the brain's reward system, the areas that make eating pleasurable. Activating those receptors with semaglutide may dull the reward signal attached to certain foods, particularly those that are high in fat or sugar.
In practice, people describe this differently. Some say a takeaway that once felt irresistible now smells a bit too strong. Others notice that they stop halfway through a meal they'd usually finish without thinking. A smaller group report that specific textures or flavours become mildly unpleasant. The semaglutide overview on our site covers the broader pharmacology if you want the full picture of how the medicine works.
The NHS notes that changes in taste or food preference are among the effects some patients report while taking medicines in this class. They tend to be most noticeable during the early titration weeks, when the dose is at its lowest starting point and the body is still adjusting. Most people find food becomes more neutral rather than actively unpleasant, a flattening of enthusiasm rather than a sharp aversion. That's not the same as the nausea that some people experience, which has a different mechanism and a different quality entirely.
GLP-1 receptors in the mesolimbic dopamine system (the brain's main reward pathway) respond to semaglutide just as they do in the gut. Research into GLP-1 receptor agonists suggests that activating these receptors reduces dopamine release in response to high-calorie food cues. The practical result is that the mental image of a burger, a packet of crisps, or a rich dessert generates less of the anticipatory pleasure it once did. The food isn't different; the signal it sends to the brain is quieter.
This is why the taste change isn't random. It tends to cluster around foods that were previously associated with a strong reward response. Vegetables, plain proteins, and lower-fat foods are often described as tasting broadly the same, sometimes even slightly better, because they're not competing against a blunted reward spike from something richer. There's ongoing research into exactly which brain regions are most involved, and the picture is still developing. What is clear is that this is a pharmacological effect of semaglutide acting centrally, not just a consequence of eating less or feeling sick.
The Wegovy treatment page explains the full licensed indication and the evidence base for the medicine if you'd like to read more before starting a conversation with a prescriber. For a deeper look at the taste-bud question specifically, the dedicated piece on whether Wegovy changes your taste buds explores the sensory side in more detail.
For most people, altered food preferences on Wegovy are a minor inconvenience or even a helpful nudge) aversion to ultra-processed foods is aligned with what the treatment is trying to achieve alongside a reduced-calorie diet. The practical risk is quieter: if certain foods become less appealing and you're already eating less overall, it becomes easier to miss adequate protein and fibre without realising it. Protein supports muscle preservation during weight loss; fibre keeps digestion moving at a time when GI side effects are already possible.
The habit that helps most is checking in with what you're actually eating, not just how much. Keeping high-protein options visible and ready (a cooked egg in the fridge door, say, or a pot of Greek yoghurt) removes the friction of preparing something when appetite is low. If taste changes feel severe, persist well beyond the first few weeks, or are affecting your ability to eat adequately, that's exactly the kind of thing to raise with your prescriber rather than push through alone.
Wegovy is a prescription medicine dispensed under clinical oversight, and your prescriber's role doesn't end at the first injection. Our frequently asked questions cover a range of practical queries about treatment, including how aftercare works. If changes in taste are making you wonder whether Wegovy is the right fit (or whether a switch might make sense) the guide on moving to Wegovy addresses that decision.
Some patients also ask whether other unexpected effects are linked to semaglutide. Changes to the menstrual cycle are one question that comes up; whether Wegovy affects your period is covered separately. And if you're already on treatment and wondering about the flexibility of your dosing schedule, changing your Wegovy injection day is another common practical question the prescribing team hears. You can read about the broader picture of semaglutide and taste changes for more on how this plays out across the full treatment course. For context on the cost of private treatment, the Wegovy pricing page explains what a legitimate prescription includes.
If you'd like to discuss how semaglutide might affect you personally, including any concerns about taste, appetite, or nutrition during treatment, start your free consultation and a GPhC-registered prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.